Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature.

Nissen MS, Blaabjerg M.

Front Neurol. 2019 Oct 2;10:1056. doi: 10.3389/fneur.2019.01056. eCollection 2019.

2.

Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis.

Brulhart L, Alpízar-Rodríguez D, Nissen MS, Zufferey P, Ciubotariu I, Fleury G, Lazarou I, Gabay C, Finckh A.

RMD Open. 2019 Aug 23;5(2):e000922. doi: 10.1136/rmdopen-2019-000922. eCollection 2019.

3.

[Stiff person syndrome: still a difficult and overlooked diagnosis].

Nissen MS, Forsberg J, Bode M, Blaabjerg M.

Ugeskr Laeger. 2019 Sep 2;181(36). pii: V03190166. Danish.

PMID:
31538571
4.

Use of Cerebrospinal Fluid Biomarkers in Diagnosis and Monitoring of Rheumatoid Meningitis.

Nissen MS, Nilsson AC, Forsberg J, Milthers J, Wirenfeldt M, Bonde C, Byg KE, Ellingsen T, Blaabjerg M.

Front Neurol. 2019 Jun 26;10:666. doi: 10.3389/fneur.2019.00666. eCollection 2019.

5.

DRESS after IV phenytoin associated with cytochrome P450 CYP2C9*3 homozygosity.

Nissen MS, Beier CP.

Neurol Genet. 2018 Sep 19;4(5):e272. doi: 10.1212/NXG.0000000000000272. eCollection 2018 Oct. No abstract available.

6.

Sinonasal adenocarcinoma following styrene exposure in the reinforced plastics industry.

Nissen MS, Stokholm ZA, Christensen MS, Schlünssen V, Vestergaard JM, Iversen IB, Kolstad HA.

Occup Environ Med. 2018 Jun;75(6):412-414. doi: 10.1136/oemed-2017-104974. Epub 2018 Mar 14.

7.

Styrene Exposure and Risk of Lymphohematopoietic Malignancies in 73,036 Reinforced Plastics Workers.

Christensen MS, Vestergaard JM, d'Amore F, Gørløv JS, Toft G, Ramlau-Hansen CH, Stokholm ZA, Iversen IB, Nissen MS, Kolstad HA.

Epidemiology. 2018 May;29(3):342-351. doi: 10.1097/EDE.0000000000000819.

PMID:
29533250
8.

Reducing Campylobacter jejuni colonization of poultry via vaccination.

Neal-McKinney JM, Samuelson DR, Eucker TP, Nissen MS, Crespo R, Konkel ME.

PLoS One. 2014 Dec 4;9(12):e114254. doi: 10.1371/journal.pone.0114254. eCollection 2014.

9.

Characterization of Solanum tuberosum multicystatin and the significance of core domains.

Green AR, Nissen MS, Kumar GN, Knowles NR, Kang C.

Plant Cell. 2013 Dec;25(12):5043-52. doi: 10.1105/tpc.113.121004. Epub 2013 Dec 20.

10.

Potential role of cardiac calsequestrin in the lethal arrhythmic effects of cocaine.

Sanchez EJ, Hayes RP, Barr JT, Lewis KM, Webb BN, Subramanian AK, Nissen MS, Jones JP, Shelden EA, Sorg BA, Fill M, Schenk JO, Kang C.

Drug Alcohol Depend. 2013 Dec 1;133(2):344-51. doi: 10.1016/j.drugalcdep.2013.06.012. Epub 2013 Jul 19.

11.

Structural characterization of 2,6-dichloro-p-hydroquinone 1,2-dioxygenase (PcpA) from Sphingobium chlorophenolicum, a new type of aromatic ring-cleavage enzyme.

Hayes RP, Green AR, Nissen MS, Lewis KM, Xun L, Kang C.

Mol Microbiol. 2013 May;88(3):523-36. doi: 10.1111/mmi.12204. Epub 2013 Mar 26.

12.

Molecular mechanisms of pharmaceutical drug binding into calsequestrin.

Subra AK, Nissen MS, Lewis KM, Muralidharan AK, Sanchez EJ, Milting H, Kang CH.

Int J Mol Sci. 2012 Nov 6;13(11):14326-43. doi: 10.3390/ijms131114326.

13.

Glycosylation of skeletal calsequestrin: implications for its function.

Sanchez EJ, Lewis KM, Munske GR, Nissen MS, Kang C.

J Biol Chem. 2012 Jan 27;287(5):3042-50. doi: 10.1074/jbc.M111.326363. Epub 2011 Dec 14.

14.

Furfural reduction mechanism of a zinc-dependent alcohol dehydrogenase from Cupriavidus necator JMP134.

Kang C, Hayes R, Sanchez EJ, Webb BN, Li Q, Hooper T, Nissen MS, Xun L.

Mol Microbiol. 2012 Jan;83(1):85-95. doi: 10.1111/j.1365-2958.2011.07914.x. Epub 2011 Nov 20.

15.

Potential adverse interaction of human cardiac calsequestrin.

Kang C, Nissen MS, Sanchez EJ, Lam KS, Milting H.

Eur J Pharmacol. 2010 Nov 10;646(1-3):12-21. doi: 10.1016/j.ejphar.2010.08.001. Epub 2010 Aug 14.

PMID:
20713040
16.

Characterization of chlorophenol 4-monooxygenase (TftD) and NADH:FAD oxidoreductase (TftC) of Burkholderia cepacia AC1100.

Webb BN, Ballinger JW, Kim E, Belchik SM, Lam KS, Youn B, Nissen MS, Xun L, Kang C.

J Biol Chem. 2010 Jan 15;285(3):2014-27. doi: 10.1074/jbc.M109.056135. Epub 2009 Nov 13.

17.

Characterization of Solanum tuberosum multicystatin and its structural comparison with other cystatins.

Nissen MS, Kumar GN, Youn B, Knowles DB, Lam KS, Ballinger WJ, Knowles NR, Kang C.

Plant Cell. 2009 Mar;21(3):861-75. doi: 10.1105/tpc.108.064717. Epub 2009 Mar 20.

18.

Crystal structures of NADH:FMN oxidoreductase (EmoB) at different stages of catalysis.

Nissen MS, Youn B, Knowles BD, Ballinger JW, Jun SY, Belchik SM, Xun L, Kang C.

J Biol Chem. 2008 Oct 17;283(42):28710-20. doi: 10.1074/jbc.M804535200. Epub 2008 Aug 12.

19.

Intrinsically disordered protein.

Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, Oh JS, Oldfield CJ, Campen AM, Ratliff CM, Hipps KW, Ausio J, Nissen MS, Reeves R, Kang C, Kissinger CR, Bailey RW, Griswold MD, Chiu W, Garner EC, Obradovic Z.

J Mol Graph Model. 2001;19(1):26-59. Review.

PMID:
11381529
21.

Purification and assays for high mobility group HMG-I(Y) protein function.

Reeves R, Nissen MS.

Methods Enzymol. 1999;304:155-88. No abstract available.

PMID:
10372360
22.

The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif.

Huth JR, Bewley CA, Nissen MS, Evans JN, Reeves R, Gronenborn AM, Clore GM.

Nat Struct Biol. 1997 Aug;4(8):657-65.

PMID:
9253416
23.

1H and 13C NMR assignments and molecular modelling of a minor groove DNA-binding peptide from the HMG-I protein.

Evans JN, Zajicek J, Nissen MS, Munske G, Smith V, Reeves R.

Int J Pept Protein Res. 1995 Jun;45(6):554-60.

PMID:
7558586
24.
25.

Replacement of conserved threonines by alanine residues in high mobility group protein HMG-I(Y): effect on DNA binding affinity.

Siino JS, Nissen MS, Reeves R.

Biochem Biophys Res Commun. 1995 Feb 15;207(2):497-507.

PMID:
7532403
26.

Cell cycle regulation and functions of HMG-I(Y).

Reeves R, Nissen MS.

Prog Cell Cycle Res. 1995;1:339-49. Review.

PMID:
9552376
27.
28.

Characterization of the proto-oncogene pim-1: kinase activity and substrate recognition sequence.

Friedmann M, Nissen MS, Hoover DS, Reeves R, Magnuson NS.

Arch Biochem Biophys. 1992 Nov 1;298(2):594-601.

PMID:
1416988
29.
30.
33.
34.

Bovine interleukin 2: regulatory mechanisms.

Magnuson NS, Spies AG, Nissen MS, Buck CD, Weinberg AD, Barr PJ, Magnuson JA, Reeves R.

Vet Immunol Immunopathol. 1987 Dec;17(1-4):183-92.

PMID:
3501631
35.
36.

Specific A . T DNA sequence binding of RP-HPLC purified HMG-I.

Elton TS, Nissen MS, Reeves R.

Biochem Biophys Res Commun. 1987 Feb 27;143(1):260-5.

PMID:
3470007
37.

Molecular cloning of a functional bovine interleukin 2 cDNA.

Reeves R, Spies AG, Nissen MS, Buck CD, Weinberg AD, Barr PJ, Magnuson NS, Magnuson JA.

Proc Natl Acad Sci U S A. 1986 May;83(10):3228-32.

38.

Metal ion binding to tetrameric lima bean lectin.

Nissen MS, Magnuson JA.

J Biol Chem. 1986 Feb 25;261(6):2514-9.

Supplemental Content

Loading ...
Support Center